Tibco Software, Inc. News, Tibco Software, Inc. Quote, IBX Quote

Tibco Software, Inc. (NY:IBX) Delayed: 20.16 +0.49 (2.49%)

Prev. Close

$19.67

Today 6M 1Y 5Y

Open

$19.32

52 Wk High

$0.90

52 Wk Low

$0.48

Day High

$20.22

Day Low

$19.30

P/E

91.64

EPS

$0.22

Volume

100,104

Friends, Peers and Foes (?): MHTX (more...)

ALERTS | RSS

Jun 25, 2026 11:52 AM Imagion Biosystems raises AU$3.75M after FDA clears Phase 2 trial
Jun 25, 2026 11:52 AM Imagion Biosystems Secures AU$3.75M in Capital Raise Following FDA Clearance of Phase 2 Clinical Trial
Jun 9, 2026 07:00 AM Presenting on Emerging Growth Conference 93 Day 1 on June 10; Register to live stream
Jun 2, 2026 11:10 AM Imagion Biosystems receives FDA clearance for MagSense breast cancer trial
Jun 2, 2026 11:10 AM Imagion Biosystems’ IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
Mar 24, 2026 08:42 AM Tradr Launches Leveraged ETFs on AMZN, AAOI, HL and IBM
Mar 23, 2026 10:43 AM Tradr Set to Launch Leveraged ETFs on AMZN, AAOI, HL and IBM
Feb 24, 2026 07:01 AM Presenting on Emerging Growth Conference 90 Day 1 on February 25; Register to live stream
Feb 3, 2026 11:30 AM Imagion Biosystems submits FDA application for HER2 breast cancer imaging trial
Feb 3, 2026 11:30 AM Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent

Entities mentioned with IBX

View All Entities